Brief: Pharmacolog I Uppsala Q4 Operating Loss Widens To SEK 3.0 Mln

Perpetua Medical AB (publ)

25/02/2022 08:06

Feb 25 (Reuters) - Pharmacolog I Uppsala AB (publ)
 PHLOGb.ST :
    * Q4 THE GROUP'S NET SALES FOR THE PERIOD AMOUNTED TO SEK
3,838
(866) THOUSAND
    * Q4 THE GROUP'S OPERATING PROFIT FOR THE PERIOD AMOUNTED TO
SEK
-2,976 (-4,449) THOUSAND.

Source text for Eikon:  ID:nWkrcC5KS 
Further company coverage:  PHLOGb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))